BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12

• Press Releases

  Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

  September 12, 2025

   · 

  5 min read
• Press Releases

  Nicholas Richardson, DO, MPH, Departs FDA and Joins Precision for Medicine as VP, Clinical Development

  September 12, 2025

   · 

  3 min read
• Press Releases

  Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold

  September 12, 2025

   · 

  9 min read
• Press Releases

  GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

  September 12, 2025

   · 

  9 min read
• Press Releases

  Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy

  September 12, 2025

   · 

  6 min read
• Press Releases

  Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings

  September 12, 2025

   · 

  4 min read
• Press Releases

  Journal of Neuro-Oncology Publishes New Data Reinforcing GammaTile® Efficacy in Treating Recurrent Brain Metastases

  September 12, 2025

   · 

  4 min read
• Press Releases

  YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC

  September 12, 2025

   · 

  1 min read
• Press Releases

  EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS

  September 12, 2025

   · 

  1 min read
• Press Releases

  Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution

  September 12, 2025

   · 

  3 min read